Standex International Corporation (FRA:9SI)

Blueprint Medicines Revenue

In the fiscal year ending June 30, 2025, Standex International had annual revenue of $790.11M USD with 9.64% growth. Standex International had revenue of $222.05M in the quarter ending June 30, 2025, with 23.23% growth.

• Revenue: $790.11M
• Revenue Growth: +9.64%
• P/S Ratio: 2.58
• Revenue / Employee: $213.54K
• Employees: 3,700
• Market Cap: 1.74B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	790.11M	69.47M	9.64%
Jun 30, 2024	720.64M	-20.41M	-2.75%
Jun 30, 2023	741.05M	5.71M	0.78%
Jun 30, 2022	735.34M	79.11M	12.05%
Jun 30, 2021	656.23M	51.70M	8.55%